BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11879774)

  • 1. Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans.
    van Bokhoven H; McKeon F
    Trends Mol Med; 2002 Mar; 8(3):133-9. PubMed ID: 11879774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P63 gene mutations and human developmental syndromes.
    Brunner HG; Hamel BC; Bokhoven Hv Hv
    Am J Med Genet; 2002 Oct; 112(3):284-90. PubMed ID: 12357472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.
    Celli J; Duijf P; Hamel BC; Bamshad M; Kramer B; Smits AP; Newbury-Ecob R; Hennekam RC; Van Buggenhout G; van Haeringen A; Woods CG; van Essen AJ; de Waal R; Vriend G; Haber DA; Yang A; McKeon F; Brunner HG; van Bokhoven H
    Cell; 1999 Oct; 99(2):143-53. PubMed ID: 10535733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
    Yang A; Kaghad M; Wang Y; Gillett E; Fleming MD; Dötsch V; Andrews NC; Caput D; McKeon F
    Mol Cell; 1998 Sep; 2(3):305-16. PubMed ID: 9774969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splitting p63.
    van Bokhoven H; Brunner HG
    Am J Hum Genet; 2002 Jul; 71(1):1-13. PubMed ID: 12037717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.
    McGrath JA; Duijf PH; Doetsch V; Irvine AD; de Waal R; Vanmolkot KR; Wessagowit V; Kelly A; Atherton DJ; Griffiths WA; Orlow SJ; van Haeringen A; Ausems MG; Yang A; McKeon F; Bamshad MA; Brunner HG; Hamel BC; van Bokhoven H
    Hum Mol Genet; 2001 Feb; 10(3):221-9. PubMed ID: 11159940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63.
    Duijf PH; Vanmolkot KR; Propping P; Friedl W; Krieger E; McKeon F; Dötsch V; Brunner HG; van Bokhoven H
    Hum Mol Genet; 2002 Apr; 11(7):799-804. PubMed ID: 11929852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27.
    Ianakiev P; Kilpatrick MW; Toudjarska I; Basel D; Beighton P; Tsipouras P
    Am J Hum Genet; 2000 Jul; 67(1):59-66. PubMed ID: 10839977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p63 gene in EEC and other syndromes.
    Brunner HG; Hamel BC; Van Bokhoven H
    J Med Genet; 2002 Jun; 39(6):377-81. PubMed ID: 12070241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.
    Westfall MD; Mays DJ; Sniezek JC; Pietenpol JA
    Mol Cell Biol; 2003 Apr; 23(7):2264-76. PubMed ID: 12640112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEC (Ectrodactyly, Ectodermal dysplasia, Clefting) syndrome: heterozygous mutation in the p63 gene (R279H) and DNA-based prenatal diagnosis.
    South AP; Ashton GH; Willoughby C; Ellis IH; Bleck O; Hamada T; Mannion G; Wessagowit V; Hashimoto T; Eady RA; McGrath JA
    Br J Dermatol; 2002 Feb; 146(2):216-20. PubMed ID: 11903230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p63.
    Little NA; Jochemsen AG
    Int J Biochem Cell Biol; 2002 Jan; 34(1):6-9. PubMed ID: 11733180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia.
    Yamaguchi H; Inokuchi K; Sakuma Y; Dan K
    Leukemia; 2001 Nov; 15(11):1729-34. PubMed ID: 11681414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p63: Molecular complexity in development and cancer.
    Westfall MD; Pietenpol JA
    Carcinogenesis; 2004 Jun; 25(6):857-64. PubMed ID: 15033906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.
    Fomenkov A; Huang YP; Topaloglu O; Brechman A; Osada M; Fomenkova T; Yuriditsky E; Trink B; Sidransky D; Ratovitski E
    J Biol Chem; 2003 Jun; 278(26):23906-14. PubMed ID: 12692135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionarily conserved expression pattern and trans-regulating activity of Xenopus p51/p63.
    Tomimori Y; Katoh I; Kurata S; Okuyama T; Kamiyama R; Ikawa Y
    Biochem Biophys Res Commun; 2004 Jan; 313(2):230-6. PubMed ID: 14684151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential recognition of response elements determines target gene specificity for p53 and p63.
    Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
    Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous mutation in the SAM domain of p63 underlies Rapp-Hodgkin ectodermal dysplasia.
    Kantaputra PN; Hamada T; Kumchai T; McGrath JA
    J Dent Res; 2003 Jun; 82(6):433-7. PubMed ID: 12766194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel p63 sterile alpha motif (SAM) domain mutation in a Japanese patient with ankyloblepharon, ectodermal defects and cleft lip and palate (AEC) syndrome without ankyloblepharon.
    Tsutsui K; Asai Y; Fujimoto A; Yamamoto M; Kubo M; Hatta N
    Br J Dermatol; 2003 Aug; 149(2):395-9. PubMed ID: 12932250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.